Trump Expands Drug Policy to Fast-Track Psychedelic Research
Here's what it means for you.
This policy shift may reshape the landscape of mental health treatment options.
What happened
Trump issued an executive order to fast-track research into psychedelics and reschedule medical marijuana.
The Context
- Notable Change: This marks a notable change in Republican drug policy.
- FDA Action: The FDA is now fast-tracking three psychedelic drugs for conditions like PTSD and depression.
- Influential Discussions: The initiative was partly inspired by a conversation between Trump and Joe Rogan.
Takeaway
This policy shift could pave the way for broader acceptance and integration of psychedelic therapies in mainstream medicine.
Insights by A47 Intelligence
Global business headlines with AI angles.
"General business outlet that frequently covers AI."
— A47 Editor
Trump Officially Flipped the Script on the War on Drugs, Issues Bold Orders on Marijuana and Psychedelics
Donald Trump has initiated a significant shift in Republican drug policy by ordering expedited research into psychedelics and moving to reschedule medical marijuana, indicating a departure from traditional stances on drug regulation.
Public health news, medical research, and wellness coverage.
"NBC News is a mainstream outlet known for comprehensive national and international news coverage with a centrist to slightly left-leaning editorial tone."
— A47 Editor
FDA Moves to Fast-Track Three Psychedelic Drugs for Review
The FDA is expediting the review process for three psychedelic drugs aimed at treating conditions such as treatment-resistant depression, major depressive disorder, and PTSD, following an executive order from President Donald Trump. This initiative r...
Capitol Hill news, legislation, and policy insight.
"The Hill specializes in U.S. politics and policy, with a focus on Capitol Hill developments and a reputation for insider reporting."
— A47 Editor
Trump’s Rogan-inspired psychedelics order stokes cautious optimism
President Donald Trump signed an executive order on April 18, 2026, aimed at loosening research restrictions on psychedelic medicine, inspired by a text from podcaster Joe Rogan. This order is designed to expedite the review process for psychedelic d...